£795.00

The 2023-2028 World Outlook for CRISPR and Cas Genes

Subjects

Price data last checked 14 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 77 days · 77 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 77 days • 1 price levels

Days at Price

Price Analysis

Most common price: £795 (77 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 77 days

Description

This study covers the world outlook for CRISPR and Cas genes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of CRISPR and Cas genes as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Addgene, Agilent Technologies, Applied StemCell, AstraZeneca, Beam Therapeutics, Calyxt, Caribou Biosciences, Cellecta, Cellectis, Cibus, CRISPR Therapeutics, Danaher Corporation, Dharmacon, Editas Medicine, Egenesis, F. Hoffmann - La Roche, Ltd., GenScript, Hera BioLabs, Horizon Discovery Group, Inscripta, Inc., Integrated DNA Technologies, Intellia Therapeutics, Lonza Group, Mammoth Biosciences, Merck KGaA, Mirus Bio, New England Biolabs, OriGene Technologies, Plantedit, Recombinetics, Inc., Sigma - Aldrich Co., LLC, Synthego, Takara Bio, Thermo Fisher Scientific, Transposagen Biopharmaceuticals, and Vertex Pharmaceuticals. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format: paperback
ASIN: B09Y9HKVTR
Category: Books > Subjects
Domain: Amazon UK
Release Date: 30 June 2022
Listed Since: 28 April 2022

The 2023-2028 World Outlook for CRISPR and Cas Genes

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2025-2030 World Outlook for CRISPR and Cas Genes

The 2023-2028 World Outlook for CRISPR Genome Editing and Genome Engineering

The 2023 Report on CRISPR and Cas Genes: World Market Segmentation by City

The 2025-2030 World Outlook for CRISPR Genome Editing and Genome Engineering

The 2025-2030 World Outlook for CRISPR Technologies

The 2023 Report on CRISPR Genome Editing and Genome Engineering: World Market Segmentation by City

The 2023-2028 World Outlook for Plant Breeding and CRISPR Plants

The 2023 Report on CRISPR-CAS9 Mice Models: World Market Segmentation by City

The 2025-2030 World Outlook for CRISPR-CAS9 Mice Models

The 2023 Report on Plant Breeding and CRISPR Plants: World Market Segmentation by City

Edición Génica: CRISPR-Cas9 en Medicina: Edición Génica para células animales y humanas

Global Regulatory Outlook for CRISPRized Plants (Genome Modified Plants and Microbes in Food and Agriculture)

Springer - Applications of CRISPR-Cas9 in Translational Research

CRC Press - Engineering Disease Resistance in Plants using CRISPR-Cas

Gene Editing by CRISPR-Cas

Academic Press - Targeted Genome Engineering via CRISPR/Cas9 in Plants

The 2016-2021 Outlook for Epigenetic Technologies in Greater China

CRISPR: Methods and Protocols: 1311 (Methods in Molecular Biology, 1311)

The 2016-2021 Outlook for Epigenetic Technologies in Japan

The 2016-2021 Outlook for Transgenic Seeds in Greater China

Gene Editing in Plants: CRISPR-Cas and Its Applications

CRISPR-Cas9 as a Revolutionary Gene Editing Tool: Genome Engineering, Advances and Applications in Agriculture

The 2016-2021 Outlook for Gene Expression Services in Japan

CRISPR Technologies - Advances in Genome Editing, Applications, and Ethical Implications (Genetics)